phenyl acetate has been researched along with Brain Vascular Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueno-Cavanillas, A; Hoxha, M; Lewis-Mikhael, AM | 1 |
| Bu, Y; Choi, H; Jamakattel-Pandit, N; Kim, H; Kim, J; Kim, MY; Leem, KH; Moon, S | 1 |
| BRENNER, H | 1 |
| BOVI, A | 1 |
| GIANNINI, G; INVERNIZZI, G | 1 |
| Chanu, B | 1 |
| Averbuch-Heller, L; Collins, SD; Leigh, RJ; Rottach, KG; Stahl, JS; von Maydell, RD | 1 |
| Nara, Y; Sawamura, M; Yamori, Y | 1 |
| Barsan, WG; Dimlich, RV; Dronen, SC; Hedges, JR; Syverud, SA | 1 |
| Hörmann, M | 1 |
| Broicher, H; Schmidt, H | 1 |
| Duus, P; Gleim, F; Herrschaft, H | 1 |
1 review(s) available for phenyl acetate and Brain Vascular Disorders
| Article | Year |
|---|---|
Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies.
Topics: Acetates; Animals; Cardiovascular Diseases; Cardiovascular System; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Risk Factors; Sulfides | 2018 |
1 trial(s) available for phenyl acetate and Brain Vascular Disorders
| Article | Year |
|---|---|
[Inhibitors of GPIIb/IIIa platelet receptors].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Cerebrovascular Disorders; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 1999 |
10 other study(ies) available for phenyl acetate and Brain Vascular Disorders
| Article | Year |
|---|---|
Key compound groups for the neuroprotective effect of roots of Polygonum cuspidatum on transient middle cerebral artery occlusion in Sprague-Dawley rats.
Topics: 1-Butanol; Acetates; Animals; Anthraquinones; Cerebrovascular Disorders; Chemical Fractionation; Chromatography, High Pressure Liquid; Fallopia japonica; Hexanes; Lipid Peroxidation; Male; Neuroprotective Agents; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rotarod Performance Test; Stilbenes | 2010 |
[On the value of dimethylaminoethyl p-chlorophenoxyacetate in the treatment of injuries and diseases of the brain].
Topics: Acetates; Brain; Brain Neoplasms; Central Nervous System Stimulants; Cerebrovascular Disorders | 1962 |
[Effects of intracarotid-injected diisopropylammonium dichloroethanoate in vasculopatic subjects. Angiographic and rheographic observations].
Topics: Acetates; Ammonium Compounds; Cerebrovascular Disorders; Humans; Quaternary Ammonium Compounds; Vascular Diseases | 1963 |
[DICHLOROETHANOATE "DIEDI" IN CEREBRAL VASCULOPATHIES].
Topics: Acetates; Ammonium Compounds; Cerebrovascular Disorders; Drug Therapy; Geriatrics; Humans; Papaverine; Quaternary Ammonium Compounds | 1964 |
A pilot study of gabapentin as treatment for acquired nystagmus.
Topics: Acetates; Adult; Amines; Anticonvulsants; Brain Stem; Cerebrovascular Disorders; Cyclohexanecarboxylic Acids; Eye Movements; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Multiple Sclerosis; Nystagmus, Pathologic; Pilot Projects; Reflex, Vestibulo-Ocular; Vision Disorders; Visual Acuity | 1996 |
Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.
Topics: Acetates; Animals; Carboxy-Lyases; Cerebrovascular Disorders; Cholesterol; Hydroxymethylglutaryl CoA Reductases; In Vitro Techniques; Kinetics; Liver; Male; Mevalonic Acid; Organ Specificity; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity | 1992 |
Effects of dichloroacetate in spinal stroke in the rabbit.
Topics: Acetates; Animals; Blood Glucose; Cerebrovascular Disorders; Dichloroacetic Acid; Lactates; Lactic Acid; Male; Movement; Rabbits; Spinal Cord; Spinal Cord Diseases; Time Factors | 1987 |
[Drug therapy of aphasic disorders following brain injury and cerebral vascular involvement].
Topics: Acetates; Aphasia; Central Nervous System Stimulants; Cerebrovascular Disorders; Craniocerebral Trauma; Humans; Meclofenoxate; Prognosis | 1973 |
[Clinical results after the treatment of cases of cerebral insufficiency with centrophenoxine (Helfergin)].
Topics: Acetates; Aged; Aging; Central Nervous System Stimulants; Cerebrovascular Disorders; Female; Humans; Male; Meclofenoxate; Middle Aged | 1970 |
[The effect of centrophenoxine on regional cerebral blood flow in man (author's transl)].
Topics: Acetates; Adult; Aged; Aphasia; Apraxias; Blood Pressure; Brain; Carotid Artery, Internal; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Hemiplegia; Humans; Injections, Intravenous; Intracranial Arteriosclerosis; Isotope Labeling; Male; Meclofenoxate; Middle Aged; Time Factors; Xenon | 1974 |